首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >17β-Estradiol Protects Human Eyelid-Derived Adipose Stem Cells against Cytotoxicity and Increases Transplanted Cell Survival in Spinal Cord injury
【2h】

17β-Estradiol Protects Human Eyelid-Derived Adipose Stem Cells against Cytotoxicity and Increases Transplanted Cell Survival in Spinal Cord injury

机译:17β-雌二醇可保护人眼睑衍生的脂肪干细胞免受细胞毒性并增加脊髓损伤中的移植细胞存活率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stem cell transplantation represents a promising strategy for the repair of spinal cord injury (SCI). However, the low survival rate of the grafted cells is a major obstacle hindering clinical success because of ongoing secondary injury processes, which includes excitotoxicity, inflammation and oxidative stress. Previous studies have shown that 17b-estradiol (E2) protects several cell types against cytotoxicity. Thus, we examined the effects of E2 on the viability of human eyelid adipose-derived stem cells (hEASCs) in vitro with hydrogen peroxide (H2O2)-induced cell model and in vivo within a rat SCI model. Our results showed that E2 protected hEASCs against H2O2-induced cell death in vitro, and enhanced the survival of grafted hEASCs in vivo by reducing apoptosis. Additionally, E2 also enhanced the secretion of growth factors by hEASCs, thereby making the local microenvironment more conducive for tissue regeneration. Overall, E2 administration enhanced the therapeutic efficacy of hEASCs transplantation and facilitated motor function recovery after SCI. Hence, E2 administration may be an intervention of choice for enhancing survival of transplanted hEASCs after SCI.
机译:干细胞移植代表了一种修复脊髓损伤(SCI)的有前途的策略。然而,由于持续的继发性损伤过程,包括兴奋性毒性,炎症和氧化应激,移植细胞的低存活率是阻碍临床成功的主要障碍。先前的研究表明17b-雌二醇(E2)保护几种细胞免受细胞毒性作用。因此,我们在体外用过氧化氢(H2O2)诱导的细胞模型以及在大鼠SCI模型中体内研究了E2对人眼睑脂肪干细胞(hEASCs)活力的影响。我们的结果表明,E2在体外保护hEASC免受H2O2诱导的细胞死亡,并通过减少细胞凋亡提高了体内移植的hEASC的存活率。另外,E2还增强了hEASCs的生长因子分泌,从而使局部微环境更有利于组织再生。总体而言,E2给药增强了hEASCs移植的治疗效果,并促进了SCI后的运动功能恢复。因此,E2给药可能是增强SCI后移植hEASC生存的选择干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号